sglt2 inhibitors vs glp 1 agonists GLP-1 Receptor and in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs SGLT2 vs GLP-1 for CKD:

It sounded almost too good to be trueand in many ways, it was

Different bodies have different needs and differences in hormonal activity, as well as microbiome diversity

The effect of GLP1 receptor agonists on dementia risk might be highly heterogeneous in routine clinical practice, implying the need to identify individuals who are more likely to benefit from their neuroprotective effects

What exactly is a GLP-1/GIP agonist

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Resistance training two to three times per week, combined with adequate protein intake, sends muscle-building signals that counteract the catabolic effects of caloric restriction